Abstract:Emerging as an important correlate of neurological dysfunction in Multiple Sclerosis (MS), extended focal and diffuse gray matter abnormalities have been found and linked to clinical manifestations such as seizures, fatigue and cognitive dysfunction. To investigate possible underlying mechanisms we analyzed the molecular alterations in histopathological normal appearing cortical gray matter (NAGM) in MS. By performing a differential gene expression analysis of NAGM of control and MS cases we identified reduced transcription of astrocyte specific genes involved in the astrocyte-neuron lactate shuttle (ANLS) and the glutamate-glutamine cycle (GGC). Additional quantitative immunohistochemical analysis demonstrating a CX43 loss in MS NAGM confirmed a crucial involvement of astrocytes and emphasizes their importance in MS pathogenesis. Concurrently, a Toll-like/IL-1β signaling expression signature was detected in MS NAGM, indicating that immune-related signaling might be responsible for the downregulation of ANLS and GGC gene expression in MS NAGM. Indeed, challenging astrocytes with immune stimuli such as IL-1β and LPS reduced their ANLS and GGC gene expression in vitro. The detected upregulation of IL1B in MS NAGM suggests inflammasome priming. For this reason, astrocyte cultures were treated with ATP and ATP/LPS as for inflammasome activation. This treatment led to a reduction of ANLS and GGC gene expression in a comparable manner. To investigate potential sources for ANLS and GGC downregulation in MS NAGM, we first performed an adjuvant-driven stimulation of the peripheral immune system in C57Bl/6 mice in vivo. This led to similar gene expression changes in spinal cord demonstrating that peripheral immune signals might be one source for astrocytic gene expression changes in the brain. IL1B upregulation in MS NAGM itself points to a possible endogenous signaling process leading to ANLS and GGC downregulation. This is supported by our findings that, among others, MS NAGM astrocytes express inflammasome components and that astrocytes are capable to release Il-1β in-vitro. Altogether, our data suggests that immune signaling of immune- and/or central nervous system origin drives alterations in astrocytic ANLS and GGC gene regulation in the MS NAGM. Such a mechanism might underlie cortical brain dysfunctions frequently encountered in MS patients.

Evaluating CXCL12 for Effects on Reactive Gene Expression in Primary Astrocytes

Genomic analysis of reactive astrogliosis

Live Imaging of Astrocyte Responses to Acute Injury Reveals Selective Juxtavascular Proliferation

Molecular and functional properties of cortical astrocytes during peripherally induced neuroinflammation

Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination

Reactive Astrocytes Display Pro-inflammatory Adaptability with Modulation of Notch-PI3K-AKT Signaling Pathway Under Inflammatory Stimulation

Toll-like receptor 4-dependent innate immune responses are mediated by intracrine corticosteroids and activation of glycogen synthase kinase-3β in astrocytes

Astrocytes Induce Hyporesponses of Myelin Basic Protein-Reactive T and B Cell Function

Interleukin-1β Induces a Reactive Astroglial Phenotype Via Deactivation of the Rho GTPase–Rock Axis

Protective Functions of Reactive Astrocytes Following Central Nervous System Insult

Elevated calcineurin activity in primary astrocytes leads to the dephosphorylation of connexin 43 in conjunction with increased membrane permeability

Metabolic gene expression changes in astrocytes in Multiple Sclerosis cerebral cortex are indicative of immune-mediated signaling

Reactive astrogliosis in the era of single-cell transcriptomics

Dynamics of reactive astrocytes fosters tissue regeneration after cuprizone-induced demyelination

Involvement of CLEC16A in Activation of Astrocytes after LPS Treated

Astrocyte-Mediated Neuroinflammation in Neurological Conditions

CX3CR1 modulates migration of resident microglia towards brain injury

Crosstalk Between Macrophages and Astrocytes Affects Proliferation, Reactive Phenotype and Inflammatory Response, Suggesting a Role During Reactive Gliosis Following Spinal Cord Injury

Stimulation of Group II Phospholipase A 2 Mrna Expression and Release in an Immortalized Astrocyte Cell Line (DITNC) by LPS, TNFα, and IL-1β

The origins and dynamic changes of C3- and S100A10-positive reactive astrocytes after spinal cord injury

Activation of epidermal growth factor receptors in astrocytes: from development to neural injury.